Over-expression of P-gp results in an active efflux of anticancer agents from cells and, consequently, a reduction of intracellular drug concentrations and an increased resistance of cancer cells to chemotherapeutic drugs, especially substrate anti-cancer drugs [18, 19]. Here, PGP is linked to cancer.